| External factors: | Doxorubicin |
| Aging type: | Accelerate |
| Aging characteristic: |
| Category: | Chemical compounds |
| Phenotype: | Aging |
| Experiment: | SA-β-gal activity assay |
| Description: | The presence of DOXO induced about 60% of SA β-gal-positive HepG2 cells and 35% of H9c2 cells. The addition of SCIC2 and SCIC2.1 led to a reduction of ~20% and ~15% in the number of SA β-gal-positive HepG2 and H9c2 cells, respectively. |
| Regulatory pathway: | -- |
| R-EF-Pathway: | -- |
| Pathway experiment: | -- |
| Pathway description: | -- |
Annotation: